Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.

CONCLUSION: The combination of genomics, proteomics, and metabolomics assays as suitable biological systems that can provide new and deeper insights into the pathogenesis of diabetes, as well as to discover prospects for developing suitable and targeted interventions. PMID: 33393899 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33393899?dopt=Abstract

Source: Current Diabetes Reviews - December 31, 2020 Category: Endocrinology Authors: Darmayanti S, Lesmana R, Meiliana A, Abdulah R Tags: Curr Diabetes Rev Source Type: research

More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology